Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This research review concluded that 5α-reductase inhibitors may be effective in treating androgenetic alopecia, showing general efficacy over placebo, though future clinical trials are needed to determine the best drug, dose, and duration, as well as gender differences in treatment response.

This study found that placebo groups in split-scalp PRP trials for androgenetic alopecia showed less hair loss compared to whole-head trial placebo groups, likely due to PRP diffusion in split-scalp designs.

This study systematically reviewed the literature on nonsurgical treatments for androgenetic alopecia, such as 5% minoxidil, platelet-rich plasma, and low-level laser therapy, but results on their relative effectiveness were not reported.

This study found similarities in the regeneration processes of MRL mouse ears and axolotl limbs, involving G2 cell cycle arrest and nerve-dependent mitosis, but the role of p21 in axolotl limb regeneration remains uncertain.

This study explored the challenges faced by both clinicians and women with polycystic ovary syndrome in managing the condition, highlighting issues with treatment options, misinformation, and differing expectations in care.

This study highlights that shock wave therapy for erectile dysfunction is commonly performed by nonurologists in major U.S. metropolitan areas, with high costs and varied treatment protocols.

This article reviews the historical development of trichology and proposes the term "trichiatrist" for physicians specializing in the medical treatment of hair and scalp, noting no new clinical findings.

This article reviews clinical practice gaps in dermatology regarding the care of patients with hair disorders, including attitude, knowledge, and skill deficiencies, and reports no new results.

This study found that 29.1% of Cochrane Skin Group reviews provided strong evidence for or against interventions, showing their potential impact on clinical decision-making.

This study found that public sentiment towards androgenetic alopecia treatments is generally negative, with over-the-counter therapies perceived more positively than prescription options despite weaker clinical evidence.

This review discusses the role of nurse navigators in managing polycystic ovary syndrome, highlighting their support in symptom management, lifestyle changes, psychosocial care, and evidence-based practices, but presents no new findings.

This study highlights the need for personalized hair care plans based on scalp type and environmental factors, underscoring the importance of targeted product selection and the involvement of professionals to create effective solutions for modern lifestyle issues.

This study highlights the importance of creating customized, evidence-based hair care solutions by considering scalp types and environmental factors, confirming the effectiveness of multidisciplinary approaches integrating dermatology, cosmetology, and trichology to develop safe and efficient products and treatments.

This source discusses the ethical dilemmas and business pressures in cosmetic dermatology, emphasizing the shift toward commercialism and profit-driven practices influenced by social media and market demands, potentially leading to conflicts of interest and professional misconduct.

This bibliometric study found a significant increase in research publications on platelet-rich plasma for hair growth from 2006 to 2023, with a shift towards examining clinical efficacy and creating evidence-based guidelines.

This review discusses the formation and goals of the Pediatric Dermatology Research Alliance (PeDRA) but reports no new clinical results; it emphasizes collaborative research to advance treatment options for pediatric skin disorders.

This review discusses various plants and herbal formulations traditionally used for hair growth and notes their potential as safer alternatives to synthetic hair loss treatments, but reports no new clinical results.

This review identifies FDA-cleared home-use photobiomodulation devices for androgenetic alopecia treatment and highlights their excellent safety profile but notes the lack of long-term comparative studies.

In this commentary, the authors discuss the challenges and proposals for responsibly translating regenerative therapies into clinical practice, emphasizing the need for patient education, quality control, and real-world evidence to validate these therapies and address ongoing misinformation in the field.

This paper outlines the structural and forensic significance of human hair, discussing its role in personal identification, drug exposure documentation, and evaluating its utility and limitations as forensic evidence without presenting new research findings.

This case report describes an adult female who developed localized hair loss on her scalp two months after tick bites, illustrating tick bite alopecia's distinct patterns and highlighting the need to consider ticks as a possible cause of such hair loss.

This source reviews the use of topical tretinoin with minoxidil for androgenetic alopecia, indicating that while combined use may convert some minoxidil nonresponders to responders, clinical evidence is limited and increased absorption may lead to irritation concerns.

This review compares regulations for herbal hair products' labeling and claim validation across various regions, identifying existing discrepancies and discussing the need for global standardization to improve consumer protection and trade facilitation.

This guideline provides evidence-based recommendations for prescribing testosterone therapy to women with hypoactive sexual desire disorder, noting a moderate therapeutic benefit but highlighting limited data and regulatory challenges.

This study reported that Longdan Xiegan decoction is more effective than conventional western medicine alone in treating eczema, but the evidence quality was generally low, highlighting the need for further studies.

This research discusses Stevens-Johnson syndrome and toxic epidermal necrolysis, life-threatening conditions often induced by immune-mediated drug reactions. Optimal management involves early diagnosis, drug withdrawal, and supportive therapy, though evidence for systemic treatments like corticosteroids and cyclosporin remains variable and lacks randomized controlled trial confirmation.

Current evidence reviewed in this study indicates that finasteride, a drug for hair loss, can cause depression and suicidality, with delayed recognition partly due to insufficient post-approval pharmacovigilance by manufacturers and regulators.

This review highlights evidence supporting the potential of blue light therapy as a non-invasive treatment for managing skin and hair conditions by modulating interactions between the skin microbiome and its host.

This study reported no evidence that clomipramine reduces overgrooming or improves hair regrowth in cats with psychogenic alopecia compared to untreated cats.

This review provides graded evidence and a therapeutic algorithm for managing hidradenitis suppurativa, but does not present new clinical results.